Inhibition mechanism and model of an angiotensin i-converting enzyme (ACE)-inhibitory hexapeptide from yeast (saccharomyces cerevisiae)

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Ni, He ^a   Li, Lin ^a   Liu, Guang ^a   Hu, Song Qing ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THREONYLPROPYLTHREONYLGLUTAMINYLGLUTAMINYLSERINE; UNCLASSIFIED DRUG; DIPEPTIDYL CARBOXYPEPTIDASE; FUNGAL PROTEIN; OLIGOPEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG PURIFICATION; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME KINETICS; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR DOCKING; NONHUMAN; PEPTIDE ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS; BINDING SITE; CALORIMETRY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; PROTEIN CONFORMATION;

SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BINDING SITES; CALORIMETRY; DRUG DISCOVERY; FUNGAL PROTEINS; KINETICS; MODELS, MOLECULAR; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; PROTEIN CONFORMATION; SACCHAROMYCES CEREVISIAE;

EID: 84860997466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037077     Document Type: Article

References (38)

1. Akif M, Georgiadis D, Mahajan A, Dive V, Sturrock ED, et al. (2010) High-resolution crystal structures of Drosophila melanogaster angiotensin-converting enzyme in complex with novel inhibitors and antihypertensive drugs. Journal of molecular biology 400: 502-517.
2. Fleming I, (2006) Signaling by the angiotensin-converting enzyme. Circulation research 98: 887-896.
3. Koike H, Ito K, Miyamoto M, Nishino H, (1980) Effects of long-term blockade of angiotensin converting enzyme with captopril (SQ14, 225) on hemodynamics and circulating blood volume in SHR. Hypertension 2: 299-303.
4. Li GH, Qu MR, Wan JZ, You JM, (2007) Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats. Asia Pac J Clin Nutr 16: 275.
5. Wei L, Clauser E, Alhenc-Gelas F, Corvol P, (1992) The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. Journal of Biological Chemistry 267: 13398-13405.
6. Vermeirssen V, Van Camp J, Verstraete W, (2004) Bioavailability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition 92: 357-366.
7. Quirós A, Dávalos A, Lasunción MA, Ramos M, Recio I, (2008) Bioavailability of the antihypertensive peptide LHLPLP: Transepithelial flux of HLPLP. International dairy journal 18: 279-286.
8. Pina A, Roque A, (2009) Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. Journal of Molecular Recognition 22: 162-168.
9. Ferreira SH, Bartelt DC, Greene LJ, (1970) Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9: 2583-2593.
10. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, et al. (1995) Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. Journal of dairy science 78: 777-783.
11. Li GH, Le GW, Shi YH, Shrestha S, (2004) Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research 24: 469-486.
12. Natesh R, Schwager SLU, Evans HR, Sturrock ED, Acharya KR, (2004) Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 43: 8718-8724.
13. Natesh R, Schwager SLU, Sturrock ED, Acharya KR, (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421: 551-554.
14. Watermeyer JM, Kroger WL, O'Neill HG, Sewell BT, Sturrock ED, (2008) Probing the Basis of Domain-Dependent Inhibition Using Novel Ketone Inhibitors of Angiotensin-Converting Enzyme? Biochemistry 47: 5942-5950.
15. Blat Y, (2010) Non-competitive Inhibition by Active Site Binders. Chemical Biology & Drug Design 75: 535-540.
16. Ni H, Li L, Guo SS, Li HH, Jiang R, et al. (2012) Isolation and Identification of an Angiotensin-I Converting Enzyme Inhibitory Peptide from Yeast (Saccharomyces cerevisiae). Current Analytical Chemistry 8: 180-185.
17. Jang JH, Jeong SC, Kim JH, Lee YH, Ju YC, et al. (2011) Characterization of a new antihypertensive angiotensin I-converting enzyme inhibitory peptide from Pleurotus cornucopiae. Food Chemistry.
18. Tsai J, Lin Y, Pan B, Chen T, (2006) Antihypertensive peptides and [gamma]-aminobutyric acid from prozyme 6 facilitated lactic acid bacteria fermentation of soymilk. Process Biochemistry 41: 1282-1288.
19. Pedroche J, Yust MM, Gironcalle J, Alaiz M, Millan F, et al. (2002) Utilisation of chickpea protein isolates for production of peptides with angiotensin I-converting enzyme (ACE)-inhibitory activity. Journal of the Science of Food and Agriculture 82: 960-965.
20. Matsufuji H, Matsui T, Seki E, Osajima K, Nakashima M, et al. (1994) Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Bioscience, biotechnology, and biochemistry 58: 2244-2245.
21. Wang J, Hu J, Cui J, Bai X, Du Y, et al. (2008) Purification and identification of a ACE inhibitory peptide from oyster proteins hydrolysate and the antihypertensive effect of hydrolysate in spontaneously hypertensive rats. Food chemistry 111: 302-308.
22. Qian ZJ, Je JY, Kim SK, (2007) Antihypertensive effect of angiotensin I converting enzyme-inhibitory peptide from hydrolysates of bigeye tuna dark muscle, Thunnus obesus. Journal of agricultural and food chemistry 55: 8398-8403.
23. Si D, Wang Y, Zhou YH, Guo Y, Wang J, et al. (2009) Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug metabolism and disposition 37: 629-634.
24. Cai L, Cao A, Lai L, (2001) An isothermal titration calorimetric method to determine the kinetic parameters of enzyme catalytic reaction by employing the product inhibition as probe. Analytical biochemistry 299: 19-23.
25. Pagano A, Ruegg D, Litschig S, Stoehr N, Stierlin C, et al. (2000) The non-competitive antagonists 2-methyl-6-(phenylethynyl) pyridine and 7-hydroxyiminocyclopropan [b] chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors. Journal of Biological Chemistry 275: 33750-33758.
26. Ciulli A, Abell C, (2005) Biophysical tools to monitor enzyme-ligand interactions of enzymes involved in vitamin biosynthesis. Biochemical Society Transactions 33: 767.
27. Seeliger D, de Groot BL, (2010) Ligand docking and binding site analysis with PyMOL and Autodock/Vina. Journal of computer-aided molecular design 24: 417-422.
28. Erdos E, (1990) Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension 16: 363-370.
29. Sturrock E, Natesh R, Rooyen J, Acharya K, (2004) Whats new in the renin-angiotensin system?: Structure of angiotensin I-converting enzyme. pp. 2677-2686 Cellular and Molecular Life Sciences CMLS.
30. Corradi HR, Schwager SLU, Nchinda AT, Sturrock ED, Acharya KR, (2006) Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. Journal of molecular biology 357: 964-974.
31. Watermeyer JM, Sewell BT, Schwager SL, Natesh R, Corradi HR, et al. (2006) Structure of testis ACE glycosylation mutants and evidence for conserved domain movement. Biochemistry 45: 12654-12663.
32. Towler P, Staker B, Prasad SG, Menon S, Tang J, et al. (2004) ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. Journal of Biological Chemistry 279: 17996-18007.
33. Cushman D, Cheung H, (1971) Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochemical Pharmacology 20: 1637-1648.
34. Yu Y, Hu J, Miyaguchi Y, Bai X, Du Y, et al. (2006) Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin. Peptides 27: 2950-2956.
35. Gowthaman U, Jayakanthan M, Sundar D, (2008) Molecular docking studies of dithionitrobenzoic acid and its related compounds to protein disulfide isomerase: computational screening of inhibitors to HIV-1 entry. BMC bioinformatics 9: S14.
36. Hariprasad G, Kumar M, Srinivasan A, Kaur P, Singh TP, et al. (2010) Structural analysis of a group III Glu62-phospholipase A2 from the scorpion, Mesobuthus tamulus: targeting and reversible inhibition by native peptides. International Journal of Biological Macromolecules.
37. Venkatachalam C, Jiang X, Oldfield T, Waldman M, (2003) LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics and Modelling 21: 289-307.
38. Liu YQ, Zhao CY, Yang L, Zhao YL, Liu TT, (2010) Evaluation of insecticidal activity of podophyllotoxin derivatives against Brontispa longissima. Pesticide Biochemistry and Physiology 99: 39-44.